A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues

Protest on PHARMAC

26 Jun 2024

The Conversation.

This week the coalition government made a significant investment in Pharmac, increasing funding by NZ$604 million over the next four years.

In doing so, it delivered on a National Party election promise to fund 13 cancer drugs. Specifically, it will fund seven of those named during the election, while the remaining six will be replaced with “as good as or better alternatives”. In total, this will fund up to 54 new drugs, including 26 cancer drugs.

This announcement finally delivers hope to many cancer patients, profits to the pharmaceutical industry, and a sigh of relief for MPs who had been accused of breaking an election promise.

Read more

Other stories

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.